Foreign investments: Bayer wants to invest more than $2 billion in US plant
Bayer is planning a new production site in Ohio and is investing $2.2 billion for this purpose. What the company expects from the location.
Bayer plans to invest $2.2 billion in a new production site in New Albany, Ohio, creating around 600 high-skilled jobs. The site will combine the production of pharmaceutical active ingredients and finished medications. Bayer's CEO, Bill Anderson, stated that the US is a key production site and innovation hub for the company. The investment is part of Bayer's larger commitment of over $7 billion in US pharmaceutical research, development, and production over the past five years.
Written by urgent.news from Handelsblatt's report — not a translation of it. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.